Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
160 participants
OBSERVATIONAL
2008-07-31
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Postoperative Atrial Fibrillation and Long-term Survival
NCT02349269
Prophylaxis for Patients at Risk to Eliminate Post-operative Atrial Fibrillation
NCT04392921
A Pharmaco-surgical Approach to Reduce Postoperative Atrial Fibrillation After Cardiac Surgery
NCT05780320
Postoperative Atrial Fibrillation in Cardiac Surgery
NCT06958029
Rate Control Versus Rhythm Control For Postoperative Atrial Fibrillation
NCT02132767
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
b-blocker
No interventions assigned to this group
amiodarone
No interventions assigned to this group
atrial pacing
No interventions assigned to this group
amiodarone plus atrial pacing
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* sinus rhythm
* undergoing either coronary artery bypass graft surgery (CABG), valvular heart surgery or a combined procedure
Exclusion Criteria
* had second or third degree heart block
* had a resting heart rate of less than 50 beats per minute
* had a systolic blood pressure less than 100 mmHg
* had severe asthma or severe chronic obstructive pulmonary disease
* had uncontrolled heart failure
* had a serum aspartate aminotransferase or alanine aminotransferase concentration greater than four times the upper limit of normal
18 Years
100 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
George Washington University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
George Washington University Hospital
Washington D.C., District of Columbia, United States
George Washington University
Washington D.C., District of Columbia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AF01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.